Dr. Soliven is the Associate Chair for Faculty Affairs in the Department of Neurology. She is the Director of the EMG Laboratory and Neuromuscular Program and sees mostly patients with myasthenia, myopathy (myositis, dystrophies), amyotrophic lateral sclerosis, autoimmune and inherited neuropathies. She is involved in neuromuscular clinical trials and studies. Her laboratory research currently focuses on glial biology and immune mechanisms pertinent to autoimmune neuropathies and myasthenia gravis (MG). She chairs the Medical Advisory Board of Conquer MG, and has served as a reviewer for multiple journals, NIH NINDS study sections, and grant review committees of other funding agencies.
University of Chicago
Chicago, IL
- Research fellowship in Glial Physiology
1989
Columbia University Medical Center
NY, NY
- EMG-Neuromuscular fellowship
1986
University of Chicago
Chicago, IL
- Neurology Residency
1985
Intermuscular coherence as an early biomarker for amyotrophic lateral sclerosis: The protocol for a prospective, multicenter study.
Intermuscular coherence as an early biomarker for amyotrophic lateral sclerosis: The protocol for a prospective, multicenter study. PLoS One. 2024; 19(5):e0303053.
PMID: 38776297
Added load increases the peak frequency of intermuscular coherence.
Added load increases the peak frequency of intermuscular coherence. J Electromyogr Kinesiol. 2024 Jun; 76:102881.
PMID: 38574588
Long-term effects of pancreatic islet transplantation on polyneuropathy in patients with brittle diabetes: A single-center experience.
Long-term effects of pancreatic islet transplantation on polyneuropathy in patients with brittle diabetes: A single-center experience. Muscle Nerve. 2023 09; 68(3):329-333.
PMID: 37439375
99m Technetium-pyrophosphate bone scan: A potential biomarker for the burden of transthyretin amyloidosis in skeletal muscle: A preliminary study.
99m Technetium-pyrophosphate bone scan: A potential biomarker for the burden of transthyretin amyloidosis in skeletal muscle: A preliminary study. Muscle Nerve. 2023 Feb; 67(2):111-116.
PMID: 36222831
Postoperative Complications of Thymectomy in Myasthenia Gravis: Does Steroid Use Play a Role?
Postoperative Complications of Thymectomy in Myasthenia Gravis: Does Steroid Use Play a Role? Ann Thorac Surg. 2023 06; 115(6):1558.
PMID: 36007565
Current Treatment of Myasthenia Gravis.
Current Treatment of Myasthenia Gravis. J Clin Med. 2022 Mar 14; 11(6).
PMID: 35329925
Progressive Multiple Mononeuropathy in a Patient With Familial Transthyretin Amyloidosis After Liver Transplantation.
Progressive Multiple Mononeuropathy in a Patient With Familial Transthyretin Amyloidosis After Liver Transplantation. J Clin Neuromuscul Dis. 2022 Mar 01; 23(3):143-147.
PMID: 35188911
Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations.
Myasthenia Gravis: Epidemiology, Pathophysiology and Clinical Manifestations. J Clin Med. 2021 May 21; 10(11).
PMID: 34064035
Drugs That Induce or Cause Deterioration of Myasthenia Gravis: An Update.
Drugs That Induce or Cause Deterioration of Myasthenia Gravis: An Update. J Clin Med. 2021 Apr 06; 10(7).
PMID: 33917535
Modulation of immune responses by bile acid receptor agonists in myasthenia gravis.
Modulation of immune responses by bile acid receptor agonists in myasthenia gravis. J Neuroimmunol. 2020 12 15; 349:577397.
PMID: 32979707